source
- Patient finds open-source diabetes app improves control despite lack of FDA approvalPatient has type 1 diabetes for over 30 years and has used FDA-approved pumps and sensors that were upgraded roughly every five years. Over time his glucose control slipped despite the regulated de…
- Liebel-Flarsheim recalls OPTIRAY imaging contrast agent after detecting plastic, metal and glass particlesLiebel-Flarsheim Company announced a recall of one lot of its OPTIRAY Imaging Bulk Package, a 350/500 mL vial of ioversol injection used for intra‑arterial and intravenous imaging. The recall was…